Driscoll pharmacist appointed Congressional Captain

Translate to Spanish or other 102 languages!

Jennifer Witte, PharmD is shown here with Congressman Michael Cloud, U.S. Representative for the 27th District of Texas

Mega Doctor News

- Advertisement -

Jennifer Witte, PharmD, a dedicated cystic fibrosis clinical pharmacist for the Driscoll Children’s Hospital Cystic Fibrosis Center who is certified by the Society of Infectious Diseases Pharmacists (SIDP) in antimicrobial stewardship, was recently appointed the Congressional Captain for TX-27 by the Cystic Fibrosis Foundation CF Advocacy Department. She is shown here with Congressman Michael Cloud, U.S. Representative for the 27th District of Texas. They met to discuss cystic fibrosis and the PASTEUR Act, which is a bill introduced to the House and Senate that aims to improve antimicrobial stewardship and the development of antibiotics.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Takes Aim at Breast Cancer with New ‘Cinco de Mammo’ Campaign

To officially kick off this year’s initiative and commemorate Cinco de Mayo, STHS hosted a special luncheon on Tuesday, May 5, 2026, a gathering rooted in compassion, courage and unity. 

Texas Rural Health Gets $56M Lifeline for Prevention and Wellness Programs

Governor Greg Abbott announced the Texas Health and Human Services Commission (HHSC) will award $56 million in federal funding to rural hospitals advancing prevention, wellness, and nutrition programs in their communities.

Op Ed: Mental Health Can’t Wait: Break the Silence, Ignite Change 

May is Mental Health Awareness Month, a national observance that has been recognized since 1949, but its message has never been more urgent. In the United States, nearly 1 in 5 adults is living with a mental health condition, and more than 1 in 20 experience a serious mental illness that significantly interferes with daily life.

Study Projects Thousands of Missed Cancer Cases Under New Medicaid Rules

A research letter from experts at the University of Chicago Medicine, published in JAMA Oncology, warns that upcoming funding cuts and changes to federal Medicaid eligibility rules could lead to dramatic reductions in cancer screening for millions of Americans, ultimately worsening patient outcomes.
- Advertisement -